Institutional Ownership
Structure Therapeutics Inc
CUSIP 86366E106SPONSORED ADSGPCRQ1 2026
13D / 13G Filings
34
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
195
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
34 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Biotechnology Value Fund L P | 13G/A | 4.9% | 10.44M | SEC |
| 2 | Feb 13, 2026 | Deep Track Capital, LP | 13G/A | 6.0% | 12.34M | SEC |
| 3 | Feb 10, 2026 | Wellington Management Group LLP | 13G/A | 10.1% | 21.37M | SEC |
| 4 | Feb 5, 2026 | Fmr LLC | 13G/A | 15.0% | 31.11M | SEC |
| 5 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 7.7% | 4.45M | SEC |
| 6 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | 7.3% | 12.65M | SEC |
| 7 | Nov 14, 2025 | Avoro Capital Advisors LLC | 13G | 9.4% | 16.22M | SEC |
| 8 | Nov 7, 2025 | Wellington Management Group LLP | 13G/A | 11.9% | 20.63M | SEC |
| 9 | Nov 7, 2025 | Wellington Management Group LLP | 13G/A | 9.9% | 17.07M | SEC |
| 10 | Aug 18, 2025 | Biotechnology Value Fund L P | 13G | 5.6% | 9.61M | SEC |
24 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Structure Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 8.40M | $405.05M |
| 2 | Wellington Management Group LLP | 7.26M | $349.95M |
| 3 | Avoro Capital Advisors LLC | 6.56M | $315.98M |
| 4 | Janus Henderson Group PLC | 5.35M | $258.26M |
| 5 | Deep Track Capital, LP | 4.28M | $206.29M |
| 6 | Bvf Inc/Il | 3.46M | $166.74M |
| 7 | Morgan Stanley | 2.31M | $111.12M |
| 8 | Principal Financial Group Inc | 1.75M | $84.53M |
| 9 | Driehaus Capital Management LLC | 1.58M | $76.03M |
| 10 | Orbimed Advisors LLC | 1.48M | $71.11M |